LDHA and ovarian carcinoma: However, the subgroup of studies with cut off value of high expression revealed that there was no association of ALDH expression with OS in ovarian cancer patients (HR: 1.40; 95%CI: 0.67–2.92), and significant heterogeneity existed using the random effects model (I2 = 63%, P = 0.07).